Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration.

Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration.

Item
http://www.wikidata.org/entity/Q36754375
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsiaThe diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient careReducing stillbirths: prevention and management of medical disorders and infections during pregnancy.Vascular and cellular calcium in normal and hypertensive pregnancyRole of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries.The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirthsNutrition transition among adolescents of a south-Mediterranean country: dietary patterns, association with socio-economic factors, overweight and blood pressure. A cross-sectional study in Tunisia.Reporting of systematic reviews of micronutrients and health: a critical appraisal.Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes.Investigation of Nutritional Behaviors in the First and Second Trimesters in Pregnant Women Referring to Clinics in Hamadan, Iran, in 2013.Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.Parathyroid and calcium metabolism disorders during pregnancy.Limited evidence for calcium supplementation in preeclampsia prevention: a meta-analysis and systematic review.Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.Urinary calcium and magnesium excretion relates to increase in blood pressure during pregnancy.The pharmacology of preventing Preeclampsia.
P2860

Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration.

Item
http://www.wikidata.org/entity/Q36754375
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Supplemental calcium and risk ...... Food and Drug Administration.
@en
type
label
Supplemental calcium and risk ...... Food and Drug Administration.
@en
prefLabel
Supplemental calcium and risk ...... Food and Drug Administration.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Supplemental calcium and risk ...... Food and Drug Administration.
@en
P2093
P304
P31
P356
10.1111/J.1753-4887.2007.TB00284.X
P433
P478
P577
P698
P921